Organization
Moscow City Oncology Hospital No.62
12 abstracts
Abstract
Ribociclib and endocrine therapy as adjuvant treatment in patients with HR+/HER2− early breast cancer: Primary results from the phase III NATALEE trial.Org: David Geffen School of Medicine at University of California Los Angeles, Moscow City Oncology Hospital No.62, Sarah Cannon Research Institute/Tennessee Oncology, Tennessee Oncology, PLLC, National Taiwan University Hospital,
Abstract
DESTINY-Breast07: Dose-expansion interim analysis of T-DXd monotherapy and T-DXd + pertuzumab in patients with previously untreated HER2+ mBC.Org: Gustave Roussy Cancer Center, Université Paris-Saclay, Villejuif, France, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN,
Abstract
Effect of trifluridine/tipiracil in combination with bevacizumab on ECOG-PS in refractory metastatic colorectal cancer: An analysis of the phase 3 SUNLIGHT trial.Org: Paris Cité University, Medical University of Vienna, City of Hope National Comprehensive Cancer Center, Università degli Studi della Campania Luigi Vanvitelli, Department of Gastroenterology/Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU Leuven,
Abstract
AGREEMENT OF INDEPENDENT CONCLUSIONS ON TYPICAL FOR GOUT RADIOLOGICAL FEATURESOrg: Metabolic group, State Institute of Rheumatology RAMS, Medical Informatics, Institute of Neurology RAMS, Outpatients clinic,
Abstract
ALCOHOL AND CARDIOVASCULAR RISK IN PATIENTS WITH GOUTOrg: Metabolic Group, Director of Institute, State Institute of Rheumatology RAMS, Moscow City Oncology Hospital No.62, Russian Federation,
Abstract
A NEW OPTION IN THE TREATMENT OF OSTHEOARTHRITIS: RESULTS OF A SIX-MONTH RANDOMIZED CLINICAL STUDYOrg: Research and Development Department, Materia Medica Holding Company, Moscow City Oncology Hospital No.62, Department of Pharmacology, Physiology, & Cell Biology at Thomas Jefferson University, Volgograd State Medical University,
Abstract
A NEW TYPE OF MONOCLONAL ANTIBODY TO CD4 FOR THE THERAPY OF RHEUMATOID ARTHRITIS (RA)Org: Immunology and Combinations, GlaxoSmithKline, Diaclone SAS, Besancon, France, Laboratory of Clinical Pharmacology,
Abstract
ANTIBODIES TO TUMOR NECROSIS FACTOR-ALFA (ANTI-TNF) AND TO INTERFERON-GAMMA (ANTI-IFN-G) IN THE THERAPY OF RHEUMATOID ARTHRITIS (RA)Org: Clinical Pharmacology and Toxicology Department, Institute of Rheumatology RAMS, Moscow City Oncology Hospital No.62, Russian Federation, Advanced Biotherapy Labs,
Abstract
AN EXPERIENCE OF RECOMBINANT GROWTH HORMONE TREATMENT IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITISOrg: Pediatric department, Institute of Rheumatology of RAMS, Moscow, Russian Federation, Endocrinology scientific Center of RAMS, Moscow City Oncology Hospital No.62, Russian Federation,
Abstract
ASSOCIATION BETWEEN HIGH-SENSITIVITY C-REACTIVE PROTEIN LEVELS AND CAROTID INTIMA MEDIA THICKNESS IN PATIENTS WITH GOUTOrg: Metabolic group, Functional diagnostics, Laboratory research, State Institute of Rheumatology RAMS, Moscow City Oncology Hospital No.62,
Abstract
ANALYSIS AT THE COHORT OF THE CONSECUTIVE PATIENTS WITH RHEUMATOID ARTHRITIS IN 2002 IN THE COMPARISON WITH 1985 YEAR: LONG-TERM OUTCOMESOrg: Consulting and Diagnostic Department, Institute of Rheumatology of RAMS, Moscow, Russian Federation, Laboratoty of Model Forecasting, Laboratory of Model Forecasting, Computer Centre of the Russian Academy of Sciences,
Abstract
AUTOANTIBODIES TO BETTA ADRENORECEPTORS IN PATIENTS WITH JUVENILE SCLERODERMAOrg: Pediatrics, CHU, Kremlin-Bicetre, Moscow Medical Sechenov Academy, Immunology, UKM, Muenster, Germany, Institute of transplantology and artificial ograns, Moscow medical Academy,